Synthése,conformation et méthanolyse des chlorures de 2,3,4-tri-O-chlorosulfonyl-β- et α-L-fucopyranosyle

Treatment of α-L-fucose with sulfuryl chloride at low temperature gave mainly 2,3,4-tri-O-chlorosulfonyl-β-L-fucopyranosyl chloride (1) and a small proportion of the α-anomer (2). Both compounds adopt a ¹C₄ chair conformation. Methanolysis of 1 in the presence of silver carbonate and anhydrous calcium sulfate gave methyl 2,3,4-tri-O-chlorosulfonyl-α-L-fucopyranoside (the β-anomer being only present in small proportion), further converted into methyl α-L-fucopyranoside by treatment with a basic resin and a catalytic amount of sodium iodide. Methanolysis of 1 in the presence of sodium iodide gave directly methyl α-L-fucopyranoside, in a more rapid but less stereoselective way. Methanolysis of 2 in the presence of silver carbonate is very slow and gave, after removal of the chlorosulfonyl groups, methyl β-L-fucopyranoside with a rather poor stereoselectivity.     

Mono- and bis-cobalt complexes with carbonyl, nitrosyl, and monocarbollide ligands

Reaction of [Co(CO)₃(NO)] with [2-NMe₃-closo-2-CB₁₀H₁₀] in refluxing CH₂Cl₂ affords the mono- and di-cobalt complexes [1-NMe₃-2-CO-2-NO-closo-2,1-CoCB₁₀H₁₀] (3) and [2,7-{Co(CO)(NO)}-7-(μ-H)-1-NMe₃-2-CO-2-NO-closo-2,1-CoCB₁₀H₉] (4), respectively, of which 4 contains formally both Co(I) and Co(-I) centers. Compound 4 reacts with CO to give 3, or with donor ligands L in the presence of Me₃NO to afford simple substituted species, [1-NMe₃-2-L-2-NO-closo-2,1-CoCB₁₀H₁₀] (compounds 5; L = PEt₃, PPh₃, CNBu^t).     

Synthesis and structural characterization of Pd(II) complexes containing 2,6-bis[(dimethylamino)methyl]-4-methylphenolate ligand

Treatment of 2,6-bis[(dimethylamino)methyl]-4-methylphenol (1) with [Pd(PhCN)₂Cl₂] in a 1:1 molar ratio gives the mononuclear Pd(II) complex [PdCl₂(OC₆H₂(CH₂NMe₂)-2-Me-4-(CH₂NHMe₂)-6)] (2) containing one ligand with an ammonium hydrogen atom, which forms a bifurcated hydrogen bonding to the phenoxy oxygen and the chlorine atoms, as shown by the single crystal X-ray diffraction study. The reaction between the lithium salt of 1 and [Pd(COD)Cl₂] gives the mononuclear Pd(II) complex [Pd(OC₆H₂(CH₂NMe₂)₂-2,6-Me-4)₂] (3). The X-ray structure of 3 showed the presence of two ligands coordinated to one palladium metal center in a trans fashion with two dangling dimethylamine groups. The yield of the complex 3 was improved by carrying out the reaction between [Pd(OAc)₂] and 1 in acetone. The solid state structures of the complexes 2 and 3 were confirmed by ¹H, ¹³C, HETCOR NMR, IR and elemental analysis methods. The ¹H NMR spectra of 2 and 3 showed two different chemical shifts corresponding to the coordinated and uncoordinated amine groups of the ligand. No decoalescence of signals for the chelate ring puckering process was observed in variable-temperature NMR spectra.     

Studies on the interconversion of 2,3'-anhydro-1-β-D-xylofuranosyluracil and 2,2'-anhydro-1-β-D-arabinofuranosyluracil

2,3'-Anhydro-1-β-D-xylofuranosyluracil (10) is converted, reversibly, into 2,2'-anhydro-1-β-D-arabinofuranosyluracil (1) in the presence of sodium tert-butoxide. The reaction probably involves 2',3'-anhydrouridine as an intermediate and equilibrium is strongly in favour of 1. The behaviour of 1 and 10 towards sodium hydroxide and sodium methoxide is described. Reaction of 3-azido-3-deoxy-2,5-di-O-p-nitrobenzoyl-β-D-xylofuranosyl chloride with monochloromercuri-4-ethoxy-2(lH)-pyrimidinone afforded crystalline 1-(3-azido-3-deoxy-2,5-di-O-p-nitrobenzoyl-β-D-xylofura-nosyl)uracil (24) in 57% yield. Alkaline methanolysis of 24 gave crystalline 1-(3-azido-3-deoxy-β-D-xylofuranosyl)uracil, which yielded 1-(3-amino-3-deoxy-β-D-xylofuranosyl)uracil (27) on hydrogenation. Deamination of 27 with nitrous acid gave mainly uracil (55%) and not the epoxide 5 or compounds derived from it.     

Synthesis of Me2LSn(o-CH3-C2B10H10): Crystal structure of Sn ← O intramolecularly coordinated organotin compound containing 1-methyl-o-carborane

The synthesis and molecular structure of Me₂LSn(1-Me-1,2-C₂B₁₀H₁₀) (3), L is 2,6-(t-BuOCH₂)₂C₆H₃⁻, the precursor for the synthesis of other Sn ← O intramolecularly coordinated organotin(IV) compounds containing 1-methyl-o-carborane (1-Me-1,2-C₂B₁₀H₁₁) is reported. Compound 3 was characterized by the help of ¹H, ¹¹B, ¹³C, ¹¹⁹Sn NMR spectroscopy and X-ray diffraction technique. For the preparation of 3, a novel triorganotin(IV) compound Me₂LSnCl (2) has been prepared since the reaction of sterically more demanding Ph₂LSnCl (1) with 1-Me-1,2-C₂B₁₀H₁₀Li did not occur.     

Photophysics of ruthenium(II) complexes carrying amino acids in the ligand 2,2′-bipyridine and intramolecular electron transfer from methionine to photogenerated Ru(III)

New ruthenium(II) complexes carrying methionine and phenylalanine in the bipyridine ligand, [Ru(bpy)₂(4-Me-4′-(CONH-l-methionine methyl ester)-2,2′-bipyridine)](PF₆)₂ (IV) and [Ru(bpy)₂(4-Me-4′-(CONH-l-phenylalanine ethyl ester)-2,2′-bpy)](PF₆)₂(V) have been synthesized and characterized and their photophysical properties studied. Flash photolysis measurements of complex IV, in the presence of an electron acceptor, methyl viologen (MV²⁺) show that an intermolecular electron transfer from the excited state of Ru(II) in complex IV, to MV²⁺ takes place, forming Ru(III) and the methyl viologen cation radical, MV⁺. The formation of MV⁺ in this system is confirmed using time-resolved transient absorption spectroscopy. This intermolecular electron transfer is followed by intramolecular electron transfer from the thioether moiety (methionine) to the photogenerated Ru(III), regenerating Ru(II).     

Crystal structure and properties of the copper(II) complex of sodium monensin A

The preparation and structural characterization of a new copper(II) complex of the polyether ionophorous antibiotic sodium monensin A (MonNa) are described. Sodium monensin A binds Cu(II) to produce a heterometallic complex of composition [Cu(MonNa)₂Cl₂]·H₂O, 1. The crystallographic data of 1 show that the complex crystallizes in monoclinic space group C2 with Cu(II) ion adopting a distorted square-planar geometry. Copper(II) coordinates two anionic sodium monensin ligands and two chloride anions producing a neutral compound. The sodium ion remains in the inner cavity of the ligand retaining its sixfold coordination with oxygen atoms. Replacement of crystallization water by acetonitrile is observed in the crystal structure of the complex 1. Copper(I) salt of the methyl ester of MonNa, 2, was identified by X-ray crystallography as a side product of the reaction of MonNa with Cu(II). Compound 2, [Me-MonNa][H-MonNa][CuCl₂]Cl, crystallizes in monoclinic space group C2 with the same coordination pattern of the sodium cation but contains a chlorocuprate(I) counter [CuCl₂]⁻, which is linear and not coordinated by sodium monensin A. The antibacterial and antioxidant properties as two independent activities of 1 were studied. Compound 1 is effective against aerobic Gram(+)-microorganisms Bacillus subtilis, Bacillus mycoides and Sarcina lutea. Complex 1 shows SOD-like activity comparable with that of the copper(II) ion.     

Synthesis of l-dopa by escherichia intermedia cells immobilized in a polyacrylamide gel

Summary Escherichia intermedia cells were immobilized by entrapment in a polyacrylamide gel and used for l-dopa synthesis from pyrocatechol, pyruvate and ammonia. An immobilized cell preparation containing 75 mg cells/g gel retained 45%–50% of the activity of free cells. The effect of temperature, pH and substrate concentration of the initial rate of l-dopa synthesis was very similar for free and immobilized cells. Substrate inhibition was observed for pyrocatechol, pyruvate and ammonia. In a batch reactor, 5.4 g·l^-1 l-dopa was obtained, with 100% conversion yield of pyrocatechol and l-dopa productivity of 0.18 g·l^-1·h^-1. The use of a pyrocatechol-borate complex decreased by-product formation and catalyst inactivation.     

Synthesis, in vitro and in silico studies of novel potent urease inhibitors: N-[4-({5-[(3-Un/substituted-anilino-3-oxopropyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1,3-thiazol-2-yl]benzamides

The present article describes the synthesis, in vitro urease inhibition and in silico molecular docking studies of a novel series of bi-heterocyclic bi-amides. The synthesis of title compounds was initiated by benzoylation, with benzoyl chloride (1), of the key starter ethyl 2-(2-amino-1,3-thiazol-4-yl)acetate (2) in weak basic aqueous medium followed by hydrazide formation, 4, and cyclization with CS₂ to reach the parent bi-heterocyclic nucleophile, N-{4-[(5-sulfanyl-1,3,4-oxadiazol-2-yl)methyl]-1,3-thiazol-2-yl}benzamide (5). Various electrophiles, 8a–l, were synthesized by a two-step process and these were finally coupled with 5 to yield the targeted bi-heterocyclic bi-amide molecules, 9a–l. The structures of the newly synthesized products were corroborated by IR, ¹H NMR, ¹³C NMR, EI-MS and elemental analysis. The in vitro screening of these molecules against urease explored that most of the compounds exhibit potent inhibitory potential against this enzyme. The compound 9j, with IC₅₀ value of 2.58?±?0.02?µM, exhibited most promising inhibitory activity among the series, relative to standard thiourea having IC₅₀ value of 21.11?±?0.12?µM. In silico studies fully augmented the experimental enzyme inhibition results. Chemo-informatics analysis showed that synthesized compounds (9a–l) mostly obeyed the Lipinski's rule. Molecular docking study suggested that ligand 9j exhibited good binding energy value (?7.10?kcal/mol) and binds within the active region of target protein. So, on the basis of present investigation, it was inferred that 9j may serve as a novel scaffold for designing more potent urease inhibitors.     

Newly synthesized Fe-doped CDs for colorimetric and fluorometric nanozyme-based levodopa sensing

A simple single-pot hydrothermal method was used to fabricate a Fe, N, and S co-doped carbon dots (Fe-CDs) nanozyme using ferric chloride and sunset yellow as precursors. The fabricated Fe-CDs exhibited intense green fluorescence at 460 nm with excitation-independent properties and a high quantum yield of 40.23%. This nanozyme mimics peroxidase by catalyzing the oxidation of tetramethylbenzidine (TMB) by H₂O₂ to yield a blue-coloured TMB_ox product at 652 nm. Dual detection methods were established for determining levodopa (l -dopa) by taking advantage of the high nanozyme activity and the distinct fluorescence aspect. Both determination methods are based on the oxidation of l -dopa by H₂O₂ in the presence of Fe-CDs and fading of the blue colour of the TMB_ox. The colorimetric method monitors the amount of colour fading of TMB_ox. In the fluorometric method, the formed blue TMB_ox absorbs the emission light of the Fe-CDs; when l -dopa is present, this effect decreases and the intensity of the emission light increases. The nanozyme-based detection procedures exhibit good linearity in the ranges 2.17 × 10⁻³ to 34.78 × 10⁻³ mM [limit of detection (LOD) = 0.84 × 10⁻³ mM] and 0.85 × 10³ to 16.95 × 10³ nM (LOD = 0.102 × 10³ nM) for colorimetric and fluorometric methods, respectively.     

Synthesis of the manganese-monocarbollide dianion [1-NHBu-2,2,2-(CO)3-closo-2,1-MnCB10H10]: Reactions with transition metal cations

Reaction of [Mn(NCMe)₃(CO)₃][PF₆] with Li₃[7-NHBu^t-nido-7-CB₁₀H₁₀] in THF (THF = tetrahydrofuran) affords the twelve-vertex manganacarborane dianion [1-NHBu^t-2,2,2-(CO)₃-closo-2,1-MnCB₁₀H₁₀]²⁻, isolated as the bis-[N(PPh₃)₂]⁺ salt (5a). This species reacts with {Pt(dppe)}²⁺ (dppe = Ph₂PCH₂CH₂PPh₂) to afford the bimetallic complex [1-NH₂Bu^t-2,3-{Pt(dppe)}-2,2,2-(CO)₃-closo-2,1-MnCB₁₀H₉] (7) which has an Mn-Pt bond. In contrast, with {Cu(PPh₃)}⁺ the anion of 5a yields a CuMnCu trimetallic compound [1-{NH(Bu^t)Cu(PPh₃)}-2,3,7-{Cu(PPh₃)}-3,7-(μ-H)₂-2,2,2-(CO)₃-closo-2,1-MnCB₁₀H₈] (8) in which one of the Cu centers is bonded to Mn, whilst the other is attached to the pendant NHBu^t group. Upon treatment with Ag⁺, compound 5a is oxidized giving the very unusual Mn(III)-carbonyl complex [1,2-μ-NHBu^t-2,2,2-(CO)₃-closo-2,1-MnCB₁₀H₁₀] (9a) in which the carborane ligand formally acts as an eight-electron donor to manganese. The novel structural features of compounds 7, 8, and 9a have been confirmed by X-ray diffraction studies.     

Synthesis of carbon-11-labeled 5-HT6R antagonists as new candidate PET radioligands for imaging of Alzheimer’s disease

Carbon-11-labeled serotonin (5-hydroxytryptamine) 6 receptor (5-HT₆R) antagonists, 1-[(2-bromophenyl)sulfonyl]-5-[¹¹C]methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole (O-[¹¹C]2a) and 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-[¹¹C]methyl-1-piperazinyl)methyl]-1H-indole (N-[¹¹C]2a), 5-[¹¹C]methoxy-3-((4-methylpiperazin-1-yl)methyl)-1-(phenylsulfonyl)-1H-indole (O-[¹¹C]2b) and 5-methoxy-3-((4-[¹¹C]methylpiperazin-1-yl)methyl)-1-(phenylsulfonyl)-1H-indole (N-[¹¹C]2b), 1-((4-isopropylphenyl)sulfonyl)-5-[¹¹C]methoxy-3-((4-methylpiperazin-1-yl)methyl)-1H-indole (O-[¹¹C]2c) and 1-((4-isopropylphenyl)sulfonyl)-5-methoxy-3-((4-[¹¹C]methylpiperazin-1-yl)methyl)-1H-indole (N-[¹¹C]2c), 1-((4-fluorophenyl)sulfonyl)-5-[¹¹C]methoxy-3-((4-methylpiperazin-1-yl)methyl)-1H-indole (O-[¹¹C]2d) and 1-((4-fluorophenyl)sulfonyl)-5-methoxy-3-((4-[¹¹C]methylpiperazin-1-yl)methyl)-1H-indole (N-[¹¹C]2d), were prepared from their O- or N-desmethylated precursors with [¹¹C]CH₃OTf through O- or N-[¹¹C]methylation and isolated by HPLC combined with SPE in 40–50% radiochemical yield, based on [¹¹C]CO₂ and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the molar activity (MA) at EOB was 370–740?GBq/μmol with a total synthesis time of ～40-min from EOB.     

Der einfluss des anomeren effektes auf furanosekonformationen. Röntgenstrukturanalyse fünf isomerer methyl-3,6-anhydrohexofuranoside

X-Ray crystallographic analysis of five isomeric methyl 3,6-anhydrohexofuranosides, methyl 3,6-anhydro-β-d-glucofuranoside (1), methyl 3,6-anhydro-α-l-idofuranoside (2), methyl 3,6-anhydro-β-d-mannofuranoside (3), methyl 3,6-anhydro-α-d-glucofuranoside (5), and methyl 3,6-anhydro-α-d-mannofuranoside (7), showed that the anomeric effect determines the conformation of the furanoid ring, which resulted in the quasi-axial orientation of the aglycon in all cases. Thus, 2 adopts an almost ideal E₂ conformation, whereas 1 and 3 having the same R configuration at the anomeric center showed conformations of the furanoid ring intermediate between E₂ and ¹T₂. Of the anomers 5 and 7 having an S configuration at C-1, 7 showed a related but opposite geometry, intermediate between ²E and ²T₁, and 5 had a ^oT₁ conformation, slightly distorted into ^oE. The anhydroring of all compounds showed a C-6 endo orientation, with the exception of 7, in which C-6 is exo oriented. These results from compounds in the solid state were compared with the conformations of the same compounds in solution, as deduced by ¹H-n.m.r. spectroscopy.     

Towards the mechanism of heteroborane isomerisation: 1,2 → 1,2 and 1,2 → 1,7 low-temperature isomerisations from metallations of [5-I-7,8-Ph2-7,8-nido-C2B9H8]

The reaction between [5-I-7,8-Ph₂-7,8-nido-C₂B₉H₈]²⁻ and NiCl₂(dppe) affords 1,2-Ph₂-4,4-dppe-12-I-4,1,2-closo-NiC₂B₉H₈ (1) and 1,8-Ph₂-2,2-dppe-10-I-2,1,8-closo-NiC₂B₉H₈ (2). Reaction between the same carborane ligand and cis-PtCl₂(PMe₂Ph)₂ yields three species, 1,8-Ph₂-2,2-(PMe₂Ph)₂-10-I-2,1,8-closo-PtC₂B₉H₈ (3), 1,8-Ph₂-2,2-(PMe₂Ph)₂-12-I-2,1,8-closo-PtC₂B₉H₈ (4), and 1,8-Ph₂-2,2-(PMe₂Ph)₂-7-I-2,1,8-closo-PtC₂B₉H₈ (5). Compounds 1-5 have been characterised spectroscopically and crystallographically. The 4,1,2-MC₂B₉ architecture of 1 constitutes a “1,2 → 1,2” cage C atom isomerisation, and the 2,1,8-MC₂B₉ architectures of 2-5 a 1,2 → 1,7 cage C atom isomerisation, relative to the presumed first product of the metallations, 1,2-Ph₂-3,3-L₂-9-I-3,1,2-closo-MC₂B₉H₈ [M = Ni, L₂ = dppe; M = Pt, L₂ = (PMe₂Ph)₂]. The location of the (iodide) labelled boron vertex in the products allows speculation as to the mechanism of these isomerisations and the possible involvement of triangle face rotation is discussed.     

Mapping the pathway of heteroborane isomerisation: Two parallel “1,2 → 1,7” isomerisations of a crowded molybdacarborane and the isolation of isomerisation intermediates

The reaction between [7,8-Ph₂-7,8-nido-C₂B₉H₉]²⁻ and [(η-C₇H₇)Mo(MeCN)₃]⁺ affords five products. Four have been isolated and shown to be structural isomers of (η-C₇H₇)MoPh₂C₂B₉H₉. Compound 1 has a pseudocloso structure. In solution it gives way to the non-icosahedral compound 2 which in turn rearranges into the “1,2 → 1,7” C-atom isomerised compound 5 having a 2,1,8-MoC₂B₉ structure. A further “1,2 → 1,7” C-atom isomerised species, compound 4, is also isolated but has a 1,2,4-MoC₂B₉ architecture. Compound 4 forms via an intermediate 3, which is too unstable to characterise. Structurally the sequence of compounds 1, 2 and 5 maps well onto the sequential diamond-square-diamond isomerisation mechanism of 1,2-closo-C₂B₁₀H₁₂ into 1,7-closo-C₂B₁₀H₁₂ proposed by Wales. An alternative pathway from the notional first product of the metallation, 1,2-Ph₂-3-(η-C₇H₇)-3,1,2-closo-MoC₂B₉H₉, is required to rationalise the intermediate compound 3 and, from it, compound 4.     

Synthesis and preliminary biological evaluation of [11C]methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucinate for the fractalkine receptor (CX3CR1)

The reference standard methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucinate (5) and its precursor 2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucine (6) were synthesized from 6-amino-2-mercaptopyrimidin-4-ol and BnBr with overall chemical yield 7% in five steps and 4% in six steps, respectively. The target tracer [¹¹C]methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucinate ([¹¹C]5) was prepared from the acid precursor with [¹¹C]CH₃OTf through O-[¹¹C]methylation and isolated by HPLC combined with SPE in 40–50% radiochemical yield, based on [¹¹C]CO₂ and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the specific activity (SA) at EOB was 370–1110 GBq/μmol with a total synthesis time of ～40-min from EOB. The radioligand depletion experiment of [¹¹C]5 did not display specific binding to CX₃CR1, and the competitive binding assay of ligand 5 found much lower CX₃CR1 binding affinity.     

Synthesis and in vivo evaluation of [11C]MPTQ: A potential PET tracer for alpha2A-adrenergic receptors

Radiosynthesis and in vivo evaluation of [N-methyl-¹¹C] 5-methyl-3-[4-(3-phenylallyl)-piperazin-1-ylmethyl]-3,3a,4,5-tetrahydroisoxazolo[4,3-c]quinoline (1), a potential PET tracer for alpha2-adrenergic receptors is described. Syntheses of nonradioactive standard 1 and corresponding desmethyl precursor 2 were achieved from 2-aminobenzaldehyde in 40% and 65% yields, respectively. Methylation using [¹¹C]CH₃I in presence of aqueous potassium hydroxide in DMSO afforded [¹¹C]1 in 25% yield (EOS) with >99% chemical and radiochemical purities with a specific activity ranged from 3–4 Ci/μmol (n = 6). The total synthesis time was 30 min from EOB. PET studies in anesthetized baboon show that [¹¹C]1 penetrates BBB and accumulates in alpha2A-AR enriched brain areas.     

The first radiosynthesis of [11C]AZD8931 as a new potential PET agent for imaging of EGFR,HER2 and HER3 signaling

The reference standard AZD8931{2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-N-methylacetamide} (11a) was synthesized from methyl 4,5-dimethoxy-2-nitrobenzoate or ethyl 4,5-dimethoxy-2-nitrobenzoate and 2-chloro-N-methylacetamide in 11 steps with 2–5% overall chemical yield. The precursor N-desmethyl-AZD8931{2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)acetamide} (11b) was synthesized from methyl 4,5-dimethoxy-2-nitrobenzoate or ethyl 4,5-dimethoxy-2-nitrobenzoate and 2-bromoacetamide in 11 steps with 2–4% overall chemical yield. The target tracer [¹¹C]AZD8931 {2-(4-((4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-N-[¹¹C]methylacetamide} ([¹¹C]11a) was prepared from N-desmethyl-AZD8931 (11b) with [¹¹C]CH₃OTf under basic condition (NaH) through N-[¹¹C]methylation and isolated by HPLC combined with solid-phase extraction (SPE) in 40–50% radiochemical yield based on [¹¹C]CO₂ and decay corrected to end of bombardment (EOB) with 370–1110 GBq/μmol specific activity at EOB.     

Syntheses stereoselectives de 1-thioglycosides

2,3,4,6-Tetra-O-acetyl-β-d-mannopyranosyl chloride (2) was obtained in 70% yield by the action of lithium chloride on 2,3,4,6-tetra-O-acetyl-α-d-mannopyranosyl bromide (1) in hexamethylphosphoric triamide. p-Nitrobenzenethiol reacted with 1 and 2 as well as with 2,3,4,6-tetra-O-acetyl-α-d-glucopyranosyl bromide (9) or its β-d-chloro analog (10), giving exclusively and in good yield the corresponding p-nitrophenyl 1-thioglycosides of inverted anomeric configuration. The 1,2-cis-d-manno and -glucop-nitrophenylglycosides were likewise prepared. α-d-Glucopyranosyl 1-thio-α-d-glucopyranoside was similarly obtained by the action of the sodium salt of 1-thio-α-d-glucopyranose on the β-chloride 10 in hexamethylphosphoric triamide, or by treatment of 10 with sodium sulfide, with subsequent deacetylation. Analogous procedures allowed the preparation of β-d-mannopyranosyl 1-thio-β-d-mann opyranoside, the corresponding α,β anomer and α-d-glucopyranosyl 1-thio-α-d-mannopyranoside, starting from bromide 1, 1-thio-α-d-mannopyranose (8),and chloride 10, respectively. When acetone was used as solvent, the reaction between 1 and 8 led instead to the α,α anomer. The thio disaccharides that are interglycosidic 4-thio analogs of methyl 4-O-(β-d-galactopyranosyl)-α-d-galactopyranoside, methyl α-cellobioside, and methyl α-maltoside, respectively, were obtained by way of the peracetates of methyl 4-thio-α-d-galactopyranoside and -glucopyranoside by reaction of the corresponding thiolates with tetra-O-acetyl-α-d-galactopyranosyl bromide, bromide 9, or chloride 10, respectively, in hexamethylphosphoric triamide. These 1-thioglycosides, and (1→1)- and (1→4)-thiodisaccharides, were characterized by ¹H- and ^{1 3}C-n.m.r. spectroscopy. Correlations were established between the polarity of the sulfur atom and certain proton and carbon chemical-shifts in the 1-thioglycosides in comparison with the O-glycosyl analogs; these correlations permitted in particular the unambigous attribution of anomeric configuration.     

Isolation of substances with antiproliferative and apoptosis-inducing activities against leukemia cells from the leaves of Zanthoxylum ailanthoides Sieb. & Zucc

Extraction of the leaves of Zanthoxylum ailanthoides Sieb. & Zucc. affords extracts and four isolated compounds which exhibit activities against leukemia cells. The chloroform-soluble fraction (ZAC) of the crude extract of this plant showed cytotoxic activity against human promyelocytic leukemia (HL-60) and myelomonocytic leukemia (WEHI-3) cells with IC₅₀ values of 73.06 and 42.22 μg/mL, respectively. The active ZAC was further separated to yield pheophorbide-a methyl ester (1), pheophorbide-b methyl ester (2), 13²-hydroxyl (13²-S) pheophorbide-a methyl ester (3) and 13²-hydroxyl (13²-R) pheophorbide-b methyl ester (4) whose structures were confirmed by spectroscopic methods. Compounds 2-4 showed cytotoxic activities against both leukemia cells with IC₅₀ value in the range of 46.76-79.43 nM, whereas compound 1 exhibited only weak cytotoxic activity. The extracts and compounds 1-4 also induced apoptosis and DNA damage in leukemia cells after treatment. The results suggested that the Z. ailanthoides is biologically active against leukemia cells.